Microfluidic Reconstitution of Tumor Microenvironment for Nanomedical Applications
Authors:
- 12 February 2021
- journal article
- review article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (9) , 2002122
Abstract
Nanoparticles have an extensive range of diagnostic and therapeutic applications in cancer treatment. However, their current clinical translation is slow, mainly due to the failure to develop preclinical evaluation techniques that can draw similar conclusions to clinical outcomes by adequately mimicking nanoparticle behavior in complicated tumor microenvironments (TMEs). Microfluidic methods offer significant advantages over conventional in vitro methods to resolve these challenges by recapitulating physiological cues of the TME such as the extracellular matrix, shear stress, interstitial flow, soluble factors, oxygen, and nutrient gradients. The methods are capable of de‐coupling microenvironmental features, spatiotemporal controlling of experimental sequences, and high throughput readouts in situ. This progress report highlights the recent achievements of microfluidic models to reconstitute the physiological microenvironment, especially for nanomedical tools for cancer treatment.Keywords
Funding Information
- National Research Foundation of Korea
This publication has 212 references indexed in Scilit:
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery systemInternational Journal of Pharmaceutics, 2012
- Microfluidic devices for modeling cell–cell and particle–cell interactions in the microvasculatureMicrovascular Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Intratumoral Drug Delivery with Nanoparticulate CarriersPharmaceutical Research, 2011
- Dynamic interplay between the collagen scaffold and tumor evolutionCurrent Opinion in Cell Biology, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progressionSeminars in Cell & Developmental Biology, 2010
- Nanoparticle-based targeted drug deliveryExperimental and Molecular Pathology, 2009
- Mechanics, malignancy, and metastasis: The force journey of a tumor cellCancer and Metastasis Reviews, 2009